CAS 1931944-80-7

Donanemab

CAS: 1931944-80-7

Donanemab (LY3002813), a humanized IgG1 antibody, targets N-terminal Aβ for potential early Alzheimer's research.

Pureza: 95%

Cor e Forma: Liquid

Peso molecular: 145.36 kDa

Ref: TM-T77162

Donanemab

CAS: 1931944-80-7

Donanemab

Pureza: ≥95%

Ref: 54-BUP20217

Donanemab

CAS: 1931944-80-7

A humanized IgG1 monoclonal antibody targets Aβ N-terminal epitope (p3-42).

Ref: 3D-CLA1552